Hydrophilic Angiographic Catheters Market Poised for 7.2% Growth, Set to Hit $57.84 Billion by 2029

What industry-specific factors are fueling the growth of the hydrophilic angiographic catheters market?
As the incidence of renal disorders continues to rise, so too does the anticipated growth of the hydrophilic angiographic catheters market. Renal disorders comprise a vast range of conditions that impede the kidneys' function, such as filtering blood, eliminating waste, maintaining fluid and electrolyte balance, and controlling blood pressure. These disorders are becoming more frequent due largely to the escalating occurrence of risk factors like diabetes, hypertension, and aging populations. Hydrophilic angiographic catheters are utilized in the management of renal disorders, allowing precise and smooth guidance during diagnostic and interventional procedures such as renal artery angiography and stenting. For example, research published by Kidney Research UK in June 2023 indicates that roughly 7.2 million UK residents live with chronic kidney disease, accounting for over 10% of the population. Of this number, 3.25 million are in the advanced stages of the disease, with an additional 3.9 million in the early stages. The number of people affected by chronic kidney disease is expected to increase to 7.61 million by 2033. As a result, the expanding incidence of renal disorders is fueling the growth of the hydrophilic angiographic catheters market.

Get Your Hydrophilic Angiographic Catheters Market Report Here:
https://www.thebusinessresearchcompany.com/report/hydrophilic-angiographic-catheters-global-market-report

What Is the projected market size and growth rate for the hydrophilic angiographic catheters market?
Recent years have witnessed substantial growth in the size of the hydrophilic angiographic catheters market. The market is projected to expand from $12.6 billion in 2024 to $13.54 billion in 2025, manifesting a compound annual growth rate (CAGR) of 7.5%. The notable increase during the historical period is attributable to factors such as the escalating prevalence of cardiovascular complications, increasing cases of peripheral vascular ailments, a surge in diagnostic and interventional operations, growing awareness leading to early diagnosis, and the swelling expenditure on healthcare.

Expect considerable expansion in the hydrophilic angiographic catheters market in the following years, with a projected escalation to $17.88 billion by 2029, at a compound annual growth rate (CAGR) of 7.2%. This demand surge during the predicted period is related to an augmenting elderly population, an escalating affinity for less invasive procedures, a heightened prevalence of diabetes, and more funds being channeled into cardiovascular exploration. Key trends for the forecast period comprise technological innovation, growth into untapped markets, breakthroughs in imaging technology, expanding application in the field of oncology, and a shift towards minimally invasive procedures.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19515&type=smp

What new trends are reshaping the hydrophilic angiographic catheters market and its opportunities?
In the hydrophilic angiographic catheters market, major corporations prioritize the development of revolutionary products such as catheters in multiple curve configurations to maintain their market stronghold. Catheters with several curve configurations are exquisitely designed medical tools featuring assorted bends or curves, optimizing their navigation through intricate anatomical structures. For example, in January 2024, Cook Group Incorporated, a medical device organization based in the US, introduced its Slip-Cath Beacon Tip hydrophilic selective catheter to the US and Canadian markets. This catheter is intended for usage in both vascular and non-vascular angiographic procedures and offers more than 30 different curve configurations. It is shipped in protective foil packaging that assures prolonged durability and a three-year shelf life. The cutting-edge technology utilized on this catheter improves its functionality during procedures and enables it to integrate seamlessly with vascular access sheaths, wire guides, and a variety of treatment devices.

What major market segments define the scope and growth of the hydrophilic angiographic catheters market?
The hydrophilic angiographic cathetersmarket covered in this report is segmented -

1) By Type: Selective Type Angiographic Catheters, Non-Selective Type Angiographic Catheters
2) By Application: Heart Disease Treatment, Kidney Disease Treatment, Other Applications
3) By End User: Hospitals, Diagnostic And Imaging Centers, Other End-Users

Subsegments:
1) By Selective Type Angiographic Catheters: Coronary Selective Catheters, Peripheral Selective Catheters, Neuro Selective Catheters
2) By Non-Selective Type Angiographic Catheters: Non-Selective Coronary Catheters, Non-Selective Peripheral Catheters, Non-Selective Neuro Catheters

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19515

Which region dominates the hydrophilic angiographic catheters market?
Asia-Pacific was the largest region in the hydrophilic angiographic catheters market in 2024. The regions covered in the hydrophilic angiographic catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the hydrophilic angiographic catheters industry growth?
Major companies operating in the hydrophilic angiographic catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Asahi Intecc Co Ltd., AngioDynamics Inc., Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Reva Medical Inc., Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, Invamed Group

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19515&type=smp

What Is Covered In The Hydrophilic Angiographic Catheters Global Market Report?

•Market Size Forecast: Examine the hydrophilic angiographic catheters market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the hydrophilic angiographic catheters market for a structured understanding.
•Key Players Overview: Analyze major players in the hydrophilic angiographic catheters market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the hydrophilic angiographic catheters market.
•Segment Contributions: Evaluate how different segments drive overall growth in the hydrophilic angiographic catheters market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the hydrophilic angiographic catheters market.
•Industry Challenges: Identify potential risks and obstacles affecting the hydrophilic angiographic catheters market.
•Competitive Landscape: Review strategic developments in the hydrophilic angiographic catheters market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.